Evidence map›Paper›PMID 36044105›Full record

ArticleDigestive diseases and sciences2023

Crohn's Disease Among the Poorest Billion: Burden of Crohn's Disease in Low- and Lower-Middle-Income Countries.

Ruma Rajbhandari, Samantha Blakemore, Neil Gupta, Sara Mannan, Klejda Nikolli, Alison Yih, Laura Drown, Gene Bukhman

Abstract read
In one paragraph

Article in Digestive diseases and sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Uphill battle: Innovation of thiopurine therapy in global inflammatory bowel disease care.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2024
    Review
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ruma RajbhandariDivision of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA. rrajbhandari@bwh.harvard.edu.ORCID http://orcid.org/0000-0001-8281-550X
Samantha BlakemoreDivision of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Neil GuptaDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, MA, 02199, USA.
Sara MannanDivision of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Klejda NikolliDivision of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Alison YihDivision of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Laura DrownDivision of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.
Gene BukhmanDivision of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo establish the epidemiology and patterns of care of Crohn's Disease in low- and lower-middle-income countries.

methodsA cross-sectional survey of gastroenterology providers in countries where the world's poorest billion live was conducted to learn more about the state of diagnostic and treatment capacity for Crohn's. Quantitative data were analyzed in R and Excel.

resultsA total of 46 survey responses from 15 countries were received, giving a response rate of 54.8%. All responses collected were from providers practicing in Africa and South Asia. The mean number of patients with Crohn's cared for in the last year was 89.5 overall but ranged from 0 reported at one facility in Rwanda to 1000 reported at two different facilities in India. Overall, Crohn's disease made up 20.6% of the inflammatory bowel disease diagnoses reported by survey respondents, with Africa exhibiting a larger proportion of Crohn's compared to ulcerative colitis than Asia. Most providers reported that patients with Crohn's have symptoms for 6-24 months prior to diagnosis and that 26-50% of their patients live in rural areas. The most reported diagnostic challenges are differentiating between Crohn's and intestinal tuberculosis, poor disease awareness, and lack of trained pathologists. The most widely reported challenge in managing Crohn's disease is patients' inability to afford biologics, reported by 65% of providers.

conclusionOur study suggests there may be a greater burden of Crohn's disease in low- and lower-middle-income countries than is indicated in prior literature. Respondents reported many challenges in diagnosing and treating Crohn's disease.

Indexed as

Colitis, UlcerativeCrohn DiseaseInflammatory Bowel DiseasesCross-Sectional StudiesDeveloping CountriesHumansCrohn’s and ColitisCrohn’s diseaseEpidemiologyHealth systemsInflammatory bowel disease

Identifiers

PMID36044105
PMCPMC10102033

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.